Net Income (Loss) Attributable to Parent in USD of iSpecimen Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
iSpecimen Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
  • iSpecimen Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$2.78M, a 93.1% decline year-over-year.
  • iSpecimen Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$11.5M, a 21.1% decline year-over-year.
  • iSpecimen Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$12.5M, a 12.6% decline from 2023.
  • iSpecimen Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$11.1M, a 8.33% decline from 2022.
  • iSpecimen Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.2M, a 14.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

iSpecimen Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$11.5M -$2.78M -$1.34M -93.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-17
Q2 2025 -$10.2M -$1.05M +$1.06M +50.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-17
Q1 2025 -$11.3M -$1.66M +$1.24M +42.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-17
Q4 2024 -$12.5M -$6.05M -$2.97M -96.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-14
Q3 2024 -$9.52M -$1.44M +$671K +31.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-17
Q2 2024 -$10.2M -$2.11M +$1.37M +39.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-17
Q1 2024 -$11.6M -$2.9M -$470K -19.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-17
Q4 2023 -$11.1M -$3.07M -$913K -42.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-14
Q3 2023 -$10.2M -$2.11M +$985K +31.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$11.2M -$3.48M -$877K -33.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$10.3M -$2.43M -$48.1K -2.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$10.2M -$2.16M -$109K -5.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$10.1M -$3.1M -$1.54M -99.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$8.59M -$2.61M -$1.21M -86.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$7.38M -$2.38M +$1.58M +39.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$8.96M -$2.05M -$457K -28.7% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-30
Q3 2021 -$8.5M -$1.55M -$307K -24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$8.2M -$1.39M -$1.22M -701% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$6.98M -$3.96M -$2.33M -142% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$4.65M -$1.59M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$1.25M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$174K Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$1.64M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04

iSpecimen Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$12.5M -$1.4M -12.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-14
2023 -$11.1M -$854K -8.33% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-14
2022 -$10.2M -$1.28M -14.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$8.96M -$4.31M -92.6% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-03-30
2020 -$4.65M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.